BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1486045)

  • 1. Transfusion-associated graft-versus-host disease, monoclonal gammopathy and PCR.
    Blundell EL; Pamphilon DH; Anderson NA; Slade RR; Burton PA; Martin A; Ray T; Bradley BA; Lawler M; Humphries P
    Br J Haematol; 1992 Nov; 82(3):622-3. PubMed ID: 1486045
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors.
    Shivdasani RA; Haluska FG; Dock NL; Dover JS; Kineke EJ; Anderson KC
    N Engl J Med; 1993 Mar; 328(11):766-70. PubMed ID: 8437597
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells.
    Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y
    Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical, nonfatal, transfusion-associated, acute graft-versus-host disease in a patient with Hodgkin's disease.
    Held JL; Druker BJ; Kohn SR; Byrnes W; Margolis RJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):261-2. PubMed ID: 1552066
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-matched blood products and posttransfusion graft-versus-host disease.
    Charpentier F; Bracq C; Bonin P; Berling P; Duedari N
    Transfusion; 1990; 30(9):850. PubMed ID: 2238036
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfusion-associated graft-versus-host disease in ataxia telangiectasia.
    Watson HG; McLaren KM; Todd A; Wallace WH
    Lancet; 1997 Jan; 349(9046):179. PubMed ID: 9111549
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion associated graft versus host disease in an immunocompetent patient.
    O'Connor NT; Mackintosh P
    J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion related graft versus host disease. Indications for irradiated blood components].
    Muñiz-Díaz E; Martínez Valverde C; Sierra J; Madoz P
    Sangre (Barc); 1999 Dec; 44(6):483-8. PubMed ID: 10822764
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular kinetics of posttransfusion graft-versus-host disease after heart operations.
    Mayumi H; Matsui K; Matsuzaki K; Uchida T; Shinozaki K; Tokunaga K
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):179-82. PubMed ID: 8028366
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
    García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C
    Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
    Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
    Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated graft-versus-host disease.
    Ortiz A; Caramelo C; Plaza JJ; Jiménez Díaz F
    N Engl J Med; 1991 Jan; 324(2):128-9. PubMed ID: 1984181
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfusion-associated graft-versus-host disease in an immunocompetent patient.
    Capon SM; DePond WD; Tyan DB; Pepkowitz SH; Toyoda H; Cinman AC; Azer PC; Goldfinger D
    Ann Intern Med; 1991 Jun; 114(12):1025-6. PubMed ID: 2029098
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood transfusions and graft-vs-host disease.
    Ray TL
    Arch Dermatol; 1990 Oct; 126(10):1347-50. PubMed ID: 2221941
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease.
    Anderson KC; Weinstein HJ
    N Engl J Med; 1990 Aug; 323(5):315-21. PubMed ID: 2248640
    [No Abstract]   [Full Text] [Related]  

  • 16. [Post-transfusion graft-versus-host disease].
    Takahashi K
    Rinsho Ketsueki; 1992 May; 33(5):582-6. PubMed ID: 1630009
    [No Abstract]   [Full Text] [Related]  

  • 17. Residual immunological risks associated with red blood cell transfusion.
    Rouger P; Le Pennec PY
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):217-9. PubMed ID: 8337131
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusion strategies in patients undergoing stem-cell transplantation.
    Radia R; Pamphilon D
    Expert Rev Hematol; 2011 Apr; 4(2):213-20. PubMed ID: 21495930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA and transfusion].
    Wittmann G; Zimmermann R; Eckstein R
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intact survival with transfusion-associated graft-versus-host disease proved by human leukocyte antigen typing of lymphocytes in skin biopsy specimens.
    Hentschel R; Broecker EB; Kolde G; Frosch M; Friedrich W; Holzgreve W; Westphal E; Harms E
    J Pediatr; 1995 Jan; 126(1):61-4. PubMed ID: 7815227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.